Characteristics of endophthalmitis in patients with the Boston keratoprosthesis

Cornea

Volumn 31, Issue 7, 2012, Pages 846-

  Ayres, Brandon D ^a  

^a WILLS EYE HOSPITAL   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

QUINOLINE DERIVED ANTIINFECTIVE AGENT; VANCOMYCIN;

ANTIMICROBIAL THERAPY; BOSTON KERATOPROSTHESIS; ENDOPHTHALMITIS; EYE PAIN; EYE REDNESS; HUMAN; INFECTION PREVENTION; KERATOPROSTHESIS; LETTER; PRIORITY JOURNAL; VISUAL DISORDER; VITRITIS;

CORNEA; ENDOPHTHALMITIS; HUMANS; PROSTHESIS IMPLANTATION; PROSTHESIS-RELATED INFECTIONS; PSEUDOMONAS INFECTIONS; STAPHYLOCOCCAL INFECTIONS;

EID: 84862865550     PISSN: 02773740     EISSN: 15364798     Source Type: Journal    
DOI: 10.1097/ICO.0b013e3181fb8823     Document Type: Letter

References (4)

1. Fintelmann RE, Maguire JI, Ho AC, et al. Characteristics of endophthalmitis in patients with the Boston keratoprosthesis. Cornea. 2009; 28:877-878.
2. Nouri M, Durand ML, Dohlman CHSudden reversible vitritis after keratoprosthesis: an immune phenomenon? Cornea. 2005;24:915-919. (Pubitemid 41688521)
3. Ormerod LD, Ho DD, Becker LE, et al. Endoph-thalmitis caused by the coagulase-negative staphylococci. 1. Disease spectrum and outcome. Ophthalmology. 1993;100:715-723. (Pubitemid 23143894)
4. Durand ML, Dohlman CHSuccessful prevention of bacterial endophthalmitis in eyes with the Boston keratoprosthesis. Cornea. 2009;28:896-901.